Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Aymen Shatnawi"'
Publikováno v:
International Journal of Breast Cancer, Vol 2024 (2024)
Conclusion: High BRAF mRNA expression as well as the gain and high-level amplification copy numbers were associated with advanced tumor characteristics and unfavorable prognostic factors in breast cancer. BRAF could be an appealing target for the tre
Externí odkaz:
https://doaj.org/article/ad746aca3aa344b8b583d9785760785a
Publikováno v:
The Breast Journal, Vol 2024 (2024)
Purpose. Breast cancer is a heterogeneous disease. Exploring new prognostic and therapeutic targets in patients with breast cancer is essential. This study investigated the expression of MET, ESR1, and ESR2 genes and their association with clinicopat
Externí odkaz:
https://doaj.org/article/00c853a6939843a8bd58d92b693bdcee
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 16 (2022)
Purpose: It has been suggested that dysregulation of transcription factors expression or activity plays significant roles in breast cancer (BC) severity and poor prognosis. Therefore, our study aims to thoroughly evaluate the estrogen-related recepto
Externí odkaz:
https://doaj.org/article/285d21c1db744a0f90ebba20fb00aa71
Autor:
Hetty E. Carraway, Sridhar A. Malkaram, Yana Cen, Aymen Shatnawi, Jun Fan, Hamdy E. A. Ali, Zakaria Y. Abd Elmageed, Thomm Buttolph, James Denvir, Donald A. Primerano, Tamer E. Fandy
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract The FDA-approved DNA hypomethylating agents (DHAs) like 5-azacytidine (5AC) and decitabine (DAC) demonstrate efficacy in the treatment of hematologic malignancies. Despite previous reports that showed histone acetylation changes upon using t
Externí odkaz:
https://doaj.org/article/d954e9fb12024afa8636559b800189b6
Autor:
Sridhar A Malkaram, Aymen Shatnawi, Jun Fan, Hetty Carraway, James Denvir, Donald A Primerano, Zakaria Y Abd Elmageed, Tamer E Fandy
Publikováno v:
Cancer Control, Vol 29 (2022)
Introduction The prototype DNA hypomethylating agents 5-azacytidine (5AC) and decitabine (DAC) are currently FDA-approved for treatment of blood and bone marrow disorders like myelodysplastic syndrome. 5AC and DAC are considered similar drugs and wer
Externí odkaz:
https://doaj.org/article/af3e480bcd5c479f8d9ddc370cd6cff9
Autor:
Dara Basyouni, Aymen Shatnawi
Publikováno v:
Journal of Medical Education and Curricular Development, Vol 7 (2020)
Introduction: This descriptive study aimed to evaluate the depth, extent, and perception of pharmacogenomics instruction in schools and colleges of medicine in the United States. Changes in medical pharmacogenomics instruction over the past decade we
Externí odkaz:
https://doaj.org/article/b216768669f34966a2870b2cbdfc0cb8
Autor:
Aymen Shatnawi, Travis Salisbury
Publikováno v:
Cancer Research. 82:P5-09
Background: Breast cancer (BC) is one of the most diagnosed tumors in the United States. The mechanism of the disease development and progression is complex and still not fully understood. Dysregulation or change in the expression of transcription fa
Autor:
Ghulam Abbas, Faisal Mohammad Ali Abdalla, Fahad Ezzi Obaid Abrah, Tawseef Ahmad, Issa Saad Al-Moraya, Mayudh Saleh Mohsen Alnefaie, Hussien Abdullah M. Alqahtani, Sami Alshakhshir, Abdulkareem Mohammed Al-Shami, Ali Salman Al-Shami, Qusai Al-Share, Yaser Mohammed Al-Worafi, Abdullah Ahmed Dhabali, Yu Fang, Nafis Haider, Muhammad Hanif, Kainat Ilyas, Ammar Ali Saleh Jaber, Asad Khan, Faiz Ullah Khan, Hafeez Ullah Khan, Yusra Habib Khan, Tauqeer Hussain Mallhi, Albaraa M. Marran, Faizan Mazhar, Long Chiau Ming, Gouri Nair, Mohamed Rashrash, Akhtar Rasul, Malik Saadullah, Suhila Sawesi, Shelley Schliesser, Muhammad Abid Shah, Shahid Shah, Aina M. Shaju, Aymen Shatnawi, Abubakar Siddique, Viswam Subeesh, Syed Azhar Syed Sulaiman, Beulah Elsa Thomas, Wasim Ullah, Farman Ullah Khan
Publikováno v:
Clinical Case Studies on Medication Safety ISBN: 9780323988025
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e12dff213e46a23290fbf3de4d005e89
https://doi.org/10.1016/b978-0-323-98802-5.09987-8
https://doi.org/10.1016/b978-0-323-98802-5.09987-8
Publikováno v:
Clinical Case Studies on Medication Safety ISBN: 9780323988025
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f1b1e9b21b2cca84f853f99972ee58a
https://doi.org/10.1016/b978-0-323-98802-5.00005-4
https://doi.org/10.1016/b978-0-323-98802-5.00005-4
Publikováno v:
Personalized medicine.
Hyperlipidemia is a significant risk factor for cardiovascular disease morbidity and mortality. The lipid-lowering drugs are considered the cornerstone of primary and secondary prevention of atherosclerotic cardiovascular disease. Unfortunately, the